print_label | resize_label
Experience that counts

A highly selective SGLT2
inhibitor for Type 2 diabetes, with 4-year safety and efficacy data, that removes glucose and its associated calories via the kidney.*1

Click here to view the FORXIGA SmPC

Combines FORXIGA, the only SGLT2 inhibitor with 4-year data, with metformin for multiple clinical benefits.*2,3

Click here to view the XIGDUO SmPC

*The efficacy of FORXIGA or XIGDUO is dependent on renal function, and efficacy is reduced in patients who have moderate renal impairment and likely absent in patients with severe renal impairment. FORXIGA and XIGDUO are not recommended for use in patients with moderate-to-severe renal impairment
(CrCl <60 mL/min or eGFR <60 mL/min/1.73 m2).1

The right product for the right patient

Use our patient profiler to understand the differences between our products.

View patient profiler

FORXIGA and XIGDUO: Two innovative options with multiple benefits for your patients with Type 2 diabetes

  • Significant and sustained HbA1c reductions1,2,6,7
  • Additional benefit of weight loss1,2,6,7
  • Additional benefit of blood pressure reductions1,2,6,7

FORXIGA and XIGDUO are not indicated for the management of obesity or high blood pressure. Weight change was a secondary endpoint, and blood pressure change was primarily assessed as a safety or exploratory efficacy endpoint in clinical trials.

FORXIGA: Experience that counts

A wealth of evidence with FORXIGA

FORXIGA, the first SGLT2 inhibitor in the world to launch, has been extensively investigated1 and widely prescribed to over 290,000 patients.4,5

FORXIGA offers 4-year efficacy data

FORXIGA is the only SGLT2 inhibitor shown to deliver multiple clinical benefits over 4 years.3

Extensive evidence for use in combination with a broad range of treatments

FORXIGA delivers consistent reductions in HbA1c when added to commonly prescribed agents.6,8–12

XIGDUO: Dual complementary action for multiple benefits

XIGDUO: Complementary MOA

XIGDUO combines two Type 2 diabetes treatments with complementary MOAs to reduce and remove excess glucose.2

Clinical benefits of XIGDUO

Sustained HbA1c reduction with the additional benefit of weight loss and blood pressure reduction.2

XIGDUO: One tablet, twice daily

XIGDUO delivers the multiple benefits of two agents in one convenient formulation.2